Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment.
The objective of this study was to determine whether neoadjuvant chemotherapy in combination with hyperthermia (HT) would improve oxygenation in locally advanced breast tumours. The study describes a new optimized ultrasound guided technique of pO2 measurement using Eppendorf polarographic oxygen probes in 18 stage IIB-III breast cancer patients. Prior to treatment, tumour hypoxia (median pO2<10 mmHg) was present in 11/18 patients (average median pO2=3.2 mmHg). Seven patients had well oxygenated tumours (median pO2 of 48.3 mmHg). Eight patients with hypoxic tumours prior to treatment had a significant improvement (p=0.0008) in tumour pO2 after treatment (pO2 increased to 19.2 mmHg). In three patients, tumours remained hypoxic (average median pO2=4.5 mmHg). The advantages of the ultrasound guided pO2 probe are in the accuracy of the Eppendorf electrode placement in tumour tissue, the ability to monitor electrode movement through the tumour tissue during the measurement and the ability to avoid electrode placement near or in large blood vessels by using colour Doppler imaging. The results of this preliminary study suggest that the combination of neoadjuvant chemotherapy and hyperthermia improves oxygenation in locally advanced breast tumours that are initially hypoxic.
Vujaskovic
Z
Z
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. vujas@radonc.duke.edu
Rosen
E L
EL
Blackwell
K L
KL
Jones
E L
EL
Brizel
D M
DM
Prosnitz
L R
LR
Samulski
T V
TV
Dewhirst
M W
MW
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004566:Electrodes; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D000860:Hypoxia; D020360:Neoadjuvant Therapy / Q000379:methods*; D010100:Oxygen / Q000378:metabolism*; D017239:Paclitaxel / Q000008:administration & dosage; D010313:Partial Pressure; D018615:Ultrasonography, Doppler, Color
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D004317:Doxorubicin; D017239:Paclitaxel; D010100:Oxygen